Addition of leumedin, N-19H-{ 2,7-dimethylfluorenyl-9-methoxy } carbonylI-L-leucine at 30-60 gM together with LDL almost completely prevented the induction of monocyte chemotactic protein mRNA, reduced monocyte chemotactic protein 1 levels by 84%, and inhibited monocyte migration into the subendothelial space of cocultures of human aortic wall cells by < 98%. LDL incubated with leumedin formed a stable complex that remained intact even after refloating in an ultracentrifuge.
Introduction
Accumulating evidence suggests that oxidized lipoproteins may play a critical role in the development of atherosclerosis (1) (2) (3) (4) (5) (6) . We previously reported that incubation of LDL with 1 . Abbreviations used in this paper: AID, antiinflammatory drugs; HAEC, human aortic endothelial cells; HASMC, human aortic smooth muscle cells; HPF, high power field; MCAF, monocyte chemotactic activating factor; LPDS, lipoprotein-deficient serum; MCP-1, monocyte chemoattractant protein 1. multilayer cocultures of human aortic endothelial cells (HAEC)' and smooth muscle cells (HASMC) resulted in mild LDL modification and a marked increase in monocyte transmigration into the subendothelial space of cocultures (7) . HDL and antioxidants prevented these LDL induced effects (7) . A new class of compounds with potent antiinflammatory effects (8) and capable of inhibiting endotoxic shock in mice (9) termed "leumedins" were recently reported. We have examined the effect of leumedins on LDL modification and monocyte transmigration in cocultures of artery wall cells. We have found that leumedins associate with LDL and HDL in vivo and effectively inhibit the modification of LDL by human aortic wall cell cocultures, and thus prevent LDL induced monocyte transmigration into the subendothelial space of the cocultures.
Methods
Materials. Tissue culture media, serum, and supplements were obtained from sources reported (7, 10) . Acetylsalycilic acid, ibuprofen, dexamethasone, indomethacin, and leucinamide were purchased from Sigma Chemical Co. (St. Louis, MO) . Purified monocyte chemotactic protein (MCP-1) and antibody to MCP-l were provided by Dr. Anthony J. Valente Cocultures. HAEC, HASMC, and human peripheral blood monocytes were isolated as previously described ( 10) . A 24-well unit previously developed and described (7) or chamber slides (Costar, Cambridge, MA) were used for the study of monocyte transmigration. The wells were treated with 0.1-0.5% gelatin (tissue culture grade, G 9391; Sigma Chemical Co.) at 37°C overnight. HASMC were seeded in the units at a confluent density of 1 X I05 cells/cm2 and cultured for 2 d, at which time they covered the entire surface of the well and had produced a substantial amount of extracellular matrix. HAEC were subsequently seeded on top ofthe matrix/HASMC at 2 x I05 cells/cm2 and allowed to grow forming a complete monolayer of confluent endothelial cells in 24 h (7, 10) . For some cocultures, the HASMC surface was treated with human fibronectin before seeding the HAEC. In these instances, the cell layer was covered with a solution of fibronectin, 20 Ag/ml medium 199 for 10 min, which was removed before seeding with HAEC. This treatment prevented HAEC detachment that sometimes occurs during subsequent incubations in the presence of low serum concentrations (i.e., 5% human serum). In all experiments, HAEC and autologous HASMC (from the same donor) were used at passage levels of 3-7. The growth medium contained 10% heat-inactivated pooled human serum and 10% fetal bovine serum in medium 199. Identical results were obtained with cocultures formed in the dif- ferent systems (i.e., polycarbonate membranes or chamber slides) and the results were independent ofwhether or not the HASMC surface was coated with fibronectin. Blood monocytes were obtained from individuals from a large pool of healthy donors by a modification of the Recalde procedure as previously described ( 12). Lipoproteins. Very low density lipoprotein (d = 1.006-1.019 g/ ml), LDL (d = 1.019-1.063 g/ml), HDL (d = 1.063-1.21 g/ml), and lipoprotein-deficient serum (LPDS) (d > 1.21 g/ml) were isolated from the sera of normal blood donors or New Zealand white rabbits by density gradient ultracentrifugation as described ( 13) and were used within 1-2 wk of isolation. The concentration of lipoproteins is expressed in terms of protein content throughout this report.
MCP-J ELISA. A direct ELISA was developed and used to determine the MCP-1 levels in coculture supernatants based on a procedure reported previously (7) . The monoclonal antibody to MCP-I was used at 1:500 to 1: 1,000 dilution.
Conjugated diene formation. The antioxidant effect of leumedin was examined by determining the pattern of formation of conjugated dienes during Cu ++ catalyzed oxidation of LDL in the absence or presence of leumedin following the method of Esterbauer et al. ( 14) or during the modification of LDL by cocultures.
Monocyte transmigration assay. The cocultures were treated with native LDL ( 100-500 pg/ml), in the absence or presence of leumedin, or other antiinflammatory compounds. The culture supernatants were subsequently transferred to untreated cocultures and were incubated for an additional 24 h. In the later stages of these studies, leumedins were added in two divided doses; the first dose was included at the time of the addition of LDL and the second dose was added 12 h later. Monocytes were labeled with the fluorescent probe Dil at 4°C for 10 min ( 15), centrifuged, and the cell pellet was resuspended in medium 199. The labeled monocytes were either immediately used or were cryopreserved for later use. At the end of the 48 h treatment, the cocultures were washed with medium 199 at 37°C and Dil-labeled monocytes were added to cocultures in the multiwell units or chamber slides at 2.5 x I05 cells/cm2 and were incubated for 40-60 min at 37°C. The medium used contained 0.5% heat-inactivated pooled human serum. The medium containing nonadherent leukocytes were then removed and cell layers were washed at 37°C to remove the loosely adherent monocytes on top of the endothelial cells. The cocultures on the polycarbonate membranes or on the slides were fixed with 10% neutral buffered formalin at room temperature for 24 h and were mounted with phosphate buffered glycerol. By this time, the HAEC monolayer had taken up a small amount of the fluorescent label from the monocytes above and below and had provided a detectable boundary that facilitated distinguishing the monocytes that were adhered above the HAEC from those that had migrated below the HAEC layer. The number of monocytes in the subendothelial space (beneath the HAECs) in a minimum of nine fields was determined under 5Ox oil objective magnification and fluorescence microscopy with a rhodamine filter set.
Association ofleumedin and aspirin with LDL. LDL samples, 5 mg each, were incubated under argon with leumedin or aspirin at final concentrations of 30 or 60 pM, in 10 ml of LPDS, 4 mg/ml, for 16 h at 37°C on a rotator (30 rpm). LDL was subsequently isolated at d = 1.019-1.063 g/ml and was dialyzed extensively against 3 X 1,000 vol of phosphate buffer. The reisolated LDL preparations were studied in the coculture system for modification and induction of monocyte transmigration. Control LDL was prepared in parallel without the addition of leumedin or aspirin.
Association of leumedin with serum components. 3H-leumedin 15669, with a specific activity of 140 x 103 cpm/ng, was incubated with 10 ml of normal human serum for 6-16 h at 370C on a rotator.
Lipoproteins and LPDS were subsequently isolated by ultracentrifugation, were extensively dialyzed against three changes of phosphate buffer, 4 The computer program OLIGOIR for the MacIntosh was used to construct optimal oligonucleotide primer pairs for MCP-1 and a-tubulin used in the PCR reaction. For quantitation ofthe PCR products, radioactive oligonucleotides were prepared by end-labeling with polynucleotide kinase using [32P] yATP, and each radioactive oligonucleotide was purified by centrifugation through a chromatography column (BioSpin; Bio-Rad Labs, Richmond, CA). 1 X 106 cpm of each of the primer pairs used was added along with the reaction mix. After the reaction was completed, 20 pI ofeach sample were applied to acrylamide gels to separate PCR products from unincorporated oligonucleotide. Acrylamide gels were fixed, dried, and scanned (Ambis Image Acquisition and Analysis; AMBIS Inc.); the AMBIS system determines the radioactive profile of the gel and digitally quantitates the radioactivity in each band. The amount of radioactivity in the PCR product for MCP-I was divided by that in the a-tubulin PCR product to normalize the data.
In vivo association ofleumedin with lipoproteins. Male New Zealand white rabbits, 2-3 kg body wt, were injected with leumedin 15669 (20 mg/kg body wt). Briefly, leumedin was dissolved in 500 p1 of dimethylsulfoxide and was injected into the ear vein, followed by injection of 2 ml ofwarm saline. Control rabbits were injected with dimethylsulfoxide vehicle and saline. LDL and HDL were isolated from the blood of rabbits obtained 24-36 h after leumedin administration and were tested in the coculture system.
Other procedures. Measurement of cell protein content and those of lipoproteins was performed by the method of Lowry et al. ( 16) and determination of cell number was carried out by standard procedures (17) .
Results
Cocultures of HAEC and HASMC were incubated in the presence of 5-10% pooled human serum and some were supplemented with 100-500 ,g/ml of LDL in the absence or presence of leumedins at different concentrations. After 24 h, the culture supernatant was removed and was incubated with untreated cocultures for an additional 24 h. The medium was then removed and human monocytes were added to the cocultures and their transmigration into the subendothelial space was determined. As shown in Fig. 2 In other experiments, native LDL at 500 jig/ml was incubated with cocultures for 24 h and LDL was reisolated from the resulting conditioned medium by density gradient ultracentrifugation. This coculture treated LDL was subsequently incubated (at 250 jig LDL/ml) with new cocultures in 5% human serum for 24 h followed by monocyte migration assay. As seen in Fig. 2 B, there was a 4.3-fold increase in the number of monocytes that migrated into the subendothelial space of cocultures incubated with this cell-modified LDL. Coincubation of the reisolated LDL with leumedin 15669 or 15199 at concentrations as high as 100 jM did not prevent the LDL induced monocyte migration (Fig. 2 B) . Similar results were obtained when LDL was incubated with cocultures and the resulting conditioned medium, without reisolating its LDL, was transferred to and incubated with fresh cocultures (data not shown). LDL modification by cocultures resulted in 170% and 173% increases in the mRNA and protein levels for MCP-1, respectively (Fig. 3, A and B) . Inclusion of leumedin 15669 together with LDL prevented the LDL-induced increases in the levels of MCP-1 message and the MCP-1 protein by 84% and 87%, respectively (Fig. 3, A and B) .
To investigate the potential antioxidant activity of leumedin, the rate and pattern of formation ofconjugated dienes was determined in samples of LDL from two different subjects during modification in cocultures using cells from 30 or 60 MM, in 10 ml of LPDS at 4 mg/ml on a rotator. LDL preparations were subsequently isolated by ultracentrifugation at d = 1.019-1.063 and were extensively dialyzed. The reisolated LDL preparations were added to cocultures at 500 yg/ml of LDL and were incubated for 48 h at 370C. Control LDL preparations, without the addition of leumedin or aspirin, were treated and reisolated in parallel (designated as LDL). Monocyte migration was examined as described for Fig. 2 A. The values are mean±SD of number of subendothelial monocytes in 36 high power fields in triplicate cocultures in four separate experiments. most effective in preventing LDL modification (compare LDL + Leumedin + Indomethacin, with LDL + Leumedin, and with LDL + Indomethacin). It should be emphasized that in the experiments described in Fig. 4 , the compounds were added to the cocultures simultaneously with the LDL.
Preincubation of LDL with leumedins at 30 MM for 5 h under argon inhibited the induced monocyte migration by 90% (Fig. 5 A) . Preincubation ofthe cocultures for 16 h with leumedins at 15 MM prevented the LDL induced monocyte migration by 58% (Fig. 5 A) .
To examine the degree of association and the stability of leumedin or aspirin with LDL, samples of LDL from several donors were incubated with or without leumedin or aspirin under argon for 6-16 h at 370C on a rotator. The LDL preparations were reisolated and used in cocultures for the studies of LDL modification and induction of monocyte migration. As shown in Fig. 5 B, preincubation of LDL with leumedin 15669 at 30 or 60 MM prevented the induced monocyte migration by 88-97% (compare LDL.Leumedin with LDL). Preincubation of LDL with aspirin, however, had no significant effect on the induced monocyte migration (compare LDL.Aspirin with LDL)..
To examine the degree of association of leumedin with serum lipoproteins, freshly isolated human serum from four different normal donors was incubated with 3H-leumedin 15669. Subsequent isolation of the lipoprotein density classes demonstrated that 3H-leumedin associated with lipoproteins to a degree that was 35-fold higher than that with the nonlipoprotein fraction (Fig. 6, A , compare ALL Lipoproteins with LPDS). Distribution among very low density lipoprotein, LDL, and HDL was similar (Fig. 6 A) .
To investigate the in vivo incorporation and association of leumedin with LDL and HDL, rabbits were injected with leumedin and subsequently the rabbit LDL and HDL were isolated and tested in the human artery wall cell cocultures. LDL isolated from control rabbits induced a 3.5-fold increase in monocyte migration (Fig. 6 B) . LDL isolated from rabbits injected with leumedin 15669 at 20 mg/kg body wt, however, was almost completely resistant to LDL modification and did not induce monocyte migration (Fig. 6 B) . To examine the protective effect of HDL against LDL modification, human LDL was used, which is more readily obtainable. HDL isolated from control rabbits prevented modification of human LDL in cocultures to a modest degree and reduced the increase in monocyte migration only by 38% (Fig. 6 B) . HDL from leumedin-injected rabbits, however, completely protected against LDL modification and hence prevented an increase in monocyte migration (Fig. 6 B) .
Discussion
Leumedins appear to be very effective in preventing human artery wall cells from modifying LDL to a biologically active molecule (Figs. 2, 3, 4 , 5, and 6 B). The effect of leumedins appeared to be confined to the events that occurred during the initial steps of LDL interaction with the artery wall cells, since leumedins did not prevent the induction of monocyte transmigration brought about by LDL that had previously been modified by a first set of cocultures and subsequently tested in a second set of untreated cocultures (Fig. 2 B) . Fig. 3 demonstrates that the LDL-induced increase in MCP-I message and protein is completely blocked by leumedin. Based on our previous findings (7), it appears likely that LDL is modified in the microenvironments formed by the extracellular matrix components produced by the interaction of HAEC and HASMC (19) (20) (21) . Antioxidants present in the serum are apparently excluded from this space. The coculture modified LDL then induces MCP-1 production by HAEC and HASMC ( Fig. 3 and reference 7), which results in the establishment ofa chemotactic gradient across the endothelial monolayer in the coculture (7). The mild degree ofmodification produced in the coculture system is presumably a result ofthe action ofprooxidants in the microenvironments largely sequestered from the effect of antioxidants present in the serum in the coculture (2, 7, 21 ) . The mechanism of LDL modification in the artery wall is not known. The modification might result from the release of superoxide anions from the artery wall cells, the action of membrane bound enzymes on LDL, and/or the transfer of cellular lipid peroxides to LDL (2, 22, 23) . The loss of antioxidants such as a-tocopherol and the peroxidation of polyunsaturated fatty acids in the LDL lipids appears to be the initiation step in the modification of LDL (23) . Preincubation of the cells with leumedins before the incubation with LDL significantly inhibited LDL modification (Fig. 5 A) . This may suggest that the artery wall cells in culture were capable of storing sufficient quantities of leumedins to prevent the subsequent release of reactive oxygen species or to inhibit the production of specific oxidized cellular lipids that have been proposed as potential contributors to the initiation oflipid oxidation in LDL (2, 23) .
While not as potent, inhibitors of the cyclooxygenase pathway (aspirin and indomethacin) and the antiinflammatory agent dexamethasone when added to the cocultures partially prevented LDL modification (Fig. 4 B) . We conclude that this effect was due in part to the ability of these compounds to partially prevent the cellular generation of reactive oxygen species. In this regard it should be noted that leumedin in combination with indomethacin was the most potent in preventing LDL modification by the coculture (Fig. 4 B) . Injection of leumedin into rabbits or in vitro incubation of LDL with leumedin produced a highly stable complex that withstood the high salt concentration and high centrifugal force applied during the isolation of the LDL in the ultracentrifuge. sented here allow us to deduce with certainty the mechanism(s) by which leumedins prevent LDL modification. The failure of leumedin to protect against the formation of conjugated dienes in LDL by either the coculture or metal ion oxidation strongly suggests that the action of leumedin is not that of a general antioxidant. Regardless ofthis, the leumedins are the only known compounds other than probucol that we have studied that associate intimately with LDL and prevent its oxidative modification. Aspirin at concentrations that are pharmacologically achievable in plasma in vivo, namely 20-30,gM, was not able to render LDL resistant to modification by the coculture and could not inhibit the resulting monocyte migration. It is well established that aspirin is rapidly metabolized in the plasma and only a small quantity of aspirin binds to albumin (24) . The complete protection of human LDL produced by in vitro preincubation of LDL with leumedins and the complete resistance of LDL isolated from leumedin injected rabbits to oxidative modification together with, complete protection against LDL modification provided by HDL from these rabbits demonstrates the remarkable association of leumedin with lipoproteins and may have significant pharmacological implications. If LDL modification is, as it appears to be ( 1, 2, 25-30), a key event in the initiation of the inflammatory reaction in atherogenesis, the association of leumedins with LDL and the resultant inhibitory effect on LDL modification observed in the present study may prove to be an effective means of preventing or reducing this modification and the resulting monocyte localization in the subendothelium. Studies in laboratory animals are underway to explore this question.
